EE9400068A - Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess - Google Patents

Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess

Info

Publication number
EE9400068A
EE9400068A EE9400068A EE9400068A EE9400068A EE 9400068 A EE9400068 A EE 9400068A EE 9400068 A EE9400068 A EE 9400068A EE 9400068 A EE9400068 A EE 9400068A EE 9400068 A EE9400068 A EE 9400068A
Authority
EE
Estonia
Prior art keywords
hbv
hepatitis
virus
infection
mixtures
Prior art date
Application number
EE9400068A
Other languages
English (en)
Estonian (et)
Inventor
W. Adair Dennis
A. Smiles Kenneth
King Dannie
Original Assignee
Oclassen Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharmaceuticals, Inc. filed Critical Oclassen Pharmaceuticals, Inc.
Publication of EE9400068A publication Critical patent/EE9400068A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9400068A 1992-04-06 1994-06-29 Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess EE9400068A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06
US95292792A 1992-09-25 1992-09-25
US07/959,004 US5432165A (en) 1992-04-06 1992-10-09 Methods for the treatment of infection caused by Hepatitis B virus (HBV)

Publications (1)

Publication Number Publication Date
EE9400068A true EE9400068A (et) 1995-12-15

Family

ID=27420427

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400068A EE9400068A (et) 1992-04-06 1994-06-29 Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess

Country Status (26)

Country Link
US (1) US5432165A (xx)
EP (1) EP0565412A1 (xx)
JP (1) JPH069403A (xx)
CN (1) CN1081879A (xx)
AP (1) AP372A (xx)
AU (1) AU662804B2 (xx)
BE (1) BE1009181A5 (xx)
BR (1) BR9306207A (xx)
CA (1) CA2092356A1 (xx)
EE (1) EE9400068A (xx)
ES (1) ES2105923B1 (xx)
FR (1) FR2689398B1 (xx)
GR (1) GR930100111A (xx)
IL (1) IL105169A0 (xx)
IT (1) IT1264332B1 (xx)
LV (1) LV10191B (xx)
MD (1) MD940152A (xx)
MX (1) MX9301922A (xx)
NO (1) NO931246L (xx)
NZ (1) NZ247188A (xx)
OA (1) OA10102A (xx)
PH (1) PH31116A (xx)
PT (1) PT101238A (xx)
SI (1) SI9300144A (xx)
WO (1) WO1993019762A1 (xx)
YU (1) YU23993A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069252A (en) * 1990-02-01 2000-05-30 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
WO1996010649A1 (en) * 1994-09-30 1996-04-11 Southwest Foundation For Biomedical Research Isolated human hepatitis b virus polymerase and uses thereof
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
US8076303B2 (en) 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
JP2012526149A (ja) * 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147774C (xx) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
CN1081879A (zh) 1994-02-16
AP372A (en) 1994-11-24
BE1009181A5 (fr) 1996-12-03
LV10191B (en) 1995-04-20
JPH069403A (ja) 1994-01-18
AU3530293A (en) 1993-10-07
ES2105923B1 (es) 1998-07-01
ITTO930226A1 (it) 1994-10-05
IL105169A0 (en) 1993-07-08
AU662804B2 (en) 1995-09-14
NZ247188A (en) 1995-05-26
NO931246D0 (no) 1993-03-31
PT101238A (pt) 1994-03-31
OA10102A (en) 1996-12-18
AP9300513A0 (en) 1993-04-30
GR930100111A (el) 1993-12-30
ITTO930226A0 (it) 1993-04-05
PH31116A (en) 1998-02-28
EP0565412A1 (en) 1993-10-13
SI9300144A (en) 1994-03-31
WO1993019762A1 (en) 1993-10-14
ES2105923A1 (es) 1997-10-16
IT1264332B1 (it) 1996-09-23
NO931246L (no) 1993-10-07
MD940152A (ro) 1995-12-31
FR2689398B1 (fr) 1994-11-18
US5432165A (en) 1995-07-11
YU23993A (sh) 1997-05-28
FR2689398A1 (fr) 1993-10-08
CA2092356A1 (en) 1993-10-07
MX9301922A (es) 1993-10-01
LV10191A (lv) 1994-10-20
BR9306207A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
LU90911I2 (fr) Antig-ne recombinant comprenant les s-quences pre-S1 et S du virus de l'h-patite B ingr-dient actif de hepacare
DK156688D0 (da) Praeparat til behandling af virusinfektioner
ZA878877B (en) Treatment of diseases caused by viruses
EP0494231A4 (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
EE9400068A (et) Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
DE69330238T2 (de) Verfahren zur Herstellung des Ectoproteins des Hepatitis-C-Virus
NO940810D0 (no) Behandling av virusinfeksjoner
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
DK384387D0 (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
ZA932271B (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
NO941839D0 (no) Fosforylerte flavanoider ved behandling av virale sykdommer
IE892593L (en) Treatment of virus diseases
BR9106503A (pt) Diagnostico e tratamento de hepatite viral
DE3883754T2 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
BR8404558A (pt) Tratamento de doencas causadas pelos virus do herpes
IE892991L (en) Treatment of viral infections
DE343258T1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
CS124988A1 (en) High-frequency sanator of virus diseases